Insider Transactions in Q1 2023 at Royalty Pharma PLC (RPRX)
Insider Transaction List (Q1 2023)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Mar 31
2023
|
Bonnie L Bassler Director |
BUY
Grant, award, or other acquisition
|
Direct |
1,049
+2.92%
|
$36,715
$35.73 P/Share
|
|
Mar 31
2023
|
Henry A Fernandez Director |
BUY
Grant, award, or other acquisition
|
Direct |
1,049
+3.49%
|
$36,715
$35.73 P/Share
|
|
Mar 30
2023
|
Rory B Riggs Director |
SELL
Open market or private sale
|
Direct |
130,024
-8.19%
|
$4,680,864
$36.26 P/Share
|
|
Mar 29
2023
|
George W. Lloyd EVP, Investments & CLO |
SELL
Open market or private sale
|
Indirect |
12,779
-5.68%
|
$472,823
$37.03 P/Share
|
|
Mar 29
2023
|
Rory B Riggs Director |
SELL
Open market or private sale
|
Direct |
9,926
-0.62%
|
$357,336
$36.95 P/Share
|
|
Mar 28
2023
|
George W. Lloyd EVP, Investments & CLO |
SELL
Open market or private sale
|
Indirect |
100,000
-30.77%
|
$3,700,000
$37.06 P/Share
|
|
Feb 23
2023
|
George W. Lloyd EVP, Investments & CLO |
SELL
Open market or private sale
|
Indirect |
25,000
-7.14%
|
$925,000
$37.27 P/Share
|
|
Feb 22
2023
|
Marshall Urist EVP, Research & Investments |
SELL
Open market or private sale
|
Direct |
23,333
-33.33%
|
$863,321
$37.3 P/Share
|
|
Feb 17
2023
|
Rory B Riggs Director |
BUY
Conversion of derivative security
|
Direct |
1,500,000
+48.44%
|
-
|
|
Feb 17
2023
|
Marshall Urist EVP, Research & Investments |
BUY
Conversion of derivative security
|
Direct |
70,000
+50.0%
|
-
|